Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group-Reference-Cited by-同舟云学术

Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group

Published:2015-03-24 Issue:4 Volume:46 Page:251-258
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Joko Kouji¹,Goto Tohru²,Watanabe Hiroshi³,Mitsuda Akari⁴,Uchida Yasushi⁵,Hasebe Chitomi⁶,Tsuruta Shotaro⁷,Kimura Hiroyuki⁸,Koike Takero⁹,Akamatsu Takuji¹⁰,Mashiba Toshie¹,Ochi Hironori¹,Nakamura Yoshiko¹,Tsuchiya Kaoru¹¹,Kurosaki Masayuki¹¹,Izumi Namiki¹¹

Affiliation:

1. Center for Liver-Biliary-Pancreatic Diseases; Matsuyama Red Cross Hospital; Matsuyama

2. Department of Gastroenterology; Japanese Red Cross Hospital Omori; Ootaku

3. Hepatology Division; Fukuoka Red Cross Hospital; Fukuoka

4. Department of Internal Medicine; Tottori Red Cross Hospital; Tottori

5. Department of Gastroenterology; Matsue Red Cross Hospital; Matsue

6. Department of Gastroenterology; Asahikawa Red Cross Hospital; Asahikawa

7. Department of Internal Medicine; Japanese Red Cross Nagasaki Genbaku Hospital; Nagasaki

8. Department of Gastroenterology; Japanese Red Cross Kyoto Daiichi Hospital; Kyoto

9. Department of Internal Medicine; Japanese Red Cross Ashikaga Hospital; Ashikaga

10. Department of Gastroenterology; Japan Red Cross Wakayama Medical Center; Wakayama

11. Department of Gastroenterology and Hepatology; Musashino Red Cross Hospital; Musashino Japan

Funder

Health and Labour Sciences Research Grant

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12515/fullpdf

Reference24 articles.

1. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis;Nishiguchi;Lancet,1995

2. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy;Yoshida;Ann Intern Med,1999

3. Cancer preventive effect of pegylated interferon α-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis;Watanabe;Hepatol Res,2011

4. Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy;Nagaoki;J Gastroenterol,2011

5. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer;Ikeda;Hepatology,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group;Journal of Viral Hepatitis;2022-05-18

2. Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents;Journal of Gastroenterology;2022-01-15

3. Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria;Journal of Gastroenterology;2020-12-05

4. Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment;Hepatology Research;2020-08-03

5. Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen;Hepatology Research;2019-07-10